10 Fibromyalgia Clinical Trials in Ann Arbor, MI (2026)

Q: How do I join a clinical trial in Ann Arbor?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you.

Recruiting Fibromyalgia Studies in Ann Arbor

NCT06855329Recruiting

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical...

Ann Arbor, MI500 participantsUniversity of Massachusetts, Worcester

View Study Details

NCT06567886Recruiting

Fibromyalgia Sleep A to ZZZ Study

This research study is testing whether changes in sleep timing and morning light therapy may have an impact on symptoms related to fibromyalgia....

Ann Arbor, MINA390 participantsUniversity of Michigan

View Study Details

NCT01973881Recruiting

Quantitative MRI for Myelofibrosis

This study is for the development and validation of functional magnetic resonance imaging (MRI) parameters as biomarkers for analyzing extent of disease and quantifying response to treatment in patien...

Ann Arbor, MI192 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT07226648Recruiting

Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia

The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four tre...

Ann Arbor, MINA180 participantsSPIRE Therapeutics Inc.

View Study Details

NCT07230288Recruiting

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) is a rare, long-lasting lung disease that causes scarring of lung tissue, shortness of breath, and loss of lung function. IPF leads to significant loss of quality o...

Ann Arbor, MIPHASE2165 participantsAbbVie

View Study Details

NCT06296394Recruiting

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators...

Ann Arbor, MI146 participantsUniversity of Pittsburgh

View Study Details

NCT06208514Recruiting

Brief Pain Exposure Therapy (BPET) For Nociplastic Pain

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies ...

Ann Arbor, MINA125 participantsUniversity of Michigan

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

Ann Arbor, MIPHASE380 participantsBoehringer Ingelheim

View Study Details

NCT06343805Recruiting

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

AJX-101 is a first-in-human (FIH), phase 1, non-randomized, multi-center, open-label clinical trial designed to investigate the safety, tolerability, pharmacokinetics (PK), clinical activity and chang...

Ann Arbor, MIPHASE176 participantsAjax Therapeutics, Inc.

View Study Details

NCT06517875Recruiting

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

The purpose of this Phase 2 study is to evaluate the efficacy and safety of momelotinib (MMB) in combination with luspatercept (LUSPA) in participants with transfusion dependence (TD) primary myelofib...

Ann Arbor, MIPHASE268 participantsGlaxoSmithKline

View Study Details

About Fibromyalgia Clinical Trials in Ann Arbor

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 10 fibromyalgia clinical trials recruiting participants in Ann Arbor, MI. These studies are seeking a combined 1,922 participants. Research is being sponsored by University of Massachusetts, Worcester, University of Michigan, University of Michigan Rogel Cancer Center and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Ann Arbor — FAQ

Are there fibromyalgia clinical trials in Ann Arbor?

Yes, there are 10 fibromyalgia clinical trials currently recruiting in Ann Arbor, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Ann Arbor?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.

Are clinical trials in Ann Arbor free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 10 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated August 28, 2026 from ClinicalTrials.gov